Click to Share

Filter News
Show All Results
News By Country
United States Remove
-Massachusetts Remove
--Watertown Remove
News By Industry
News By Tag
None Found
News By Subject
None Found

September 2021

Public Company News

Business Press Releases

Watertown Latest News (Massachusetts, United States)

+ Alert
+ Feed
Exclusive News
Topics Locations Industries Dates

30 views, By Biochempeg Scientific Inc.
The FDA amended the emergency use authorizations (EUAs) for both the Pfizer-BioNTech & the Moderna COVID-19 Vaccine to allow for the use of an additional dose in certain immunocompromised individuals.
14 views, By Biochempeg Scientific Inc.
Unlike common diseases such as colds and coughs, cancer is a more significant disease with a high mortality rate. Globally, cancer causes the second largest number of deaths after cardiovascular disease.
19 views, By Biochempeg Scientific Inc.
Monodisperse PEG products usually are organic compounds with a molecular weight of less than 1000. Monodispersed PEG linkers are pure compounds with a single molecular weight.
291 views, By Addgene
Addgene, the nonprofit plasmid repository, has been awarded a grant from the National Institutes of Health (NIH) to develop a recombinant antibody resource.
37 views, By Biochempeg Scientific Inc.
The Pfizer-BioNTech COVID-19 mRNA vaccine (Tozinameran or BNT162b2) is used to protect against COVID-19. This disease is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
238 views, By Addgene
Addgene, the global nonprofit biorepository that facilitates sharing of life science reagents, today announced the departure of Joanne Kamens, Ph.D., Addgene's Executive Director.
301 views, By ABG Realty
Associated Brokerage Group's Talia Abrams-Kudan and Stephanie Deering recently represented Indigo Fire in finding a second location for their well reputed pottery studio.
47 views, By Biochempeg Scientific Inc.
The FDA has granted accelerated approval to Sacituzumab Govitecan on April 13, 2021 for use in adult patients with locally advanced or metastatic urothelial cancer who have previously received platinum-containing chemotherapy and either a programmed...
1044 views, By Addgene
Addgene, the nonprofit biorepository, can now help accelerate scientific discovery even faster through the donation of an Illumina MiSeq from Jane and Mark Hirsh.
51 views, By Biochempeg Scientific Inc.
On April 22, the FDA approved sacituzumab govitecan for the treatment of adult patients with metastatic triple-negative breast cancer who have received at least two prior therapies for metastatic disease.
59 views, By Biochempeg Scientific Inc.
Immunotherapy, treatment of cancer with substances that strengthen the body's natural immune response, is the most prominent topic within melanoma research, accounting for 4.9 percent of papers published between 2013 and 2018.
41 views, By Biochempeg Scientific Inc.
Two new medications commonly used to treat type 2 diabetes are similar in their ability to reduce major heart complications, including heart attack, stroke and death from cardiovascular disease, according to research accepted for presentation at ENDO...
61 views, By Biochempeg
Physician-scientists in the Cancer Center at Children's Hospital of Philadelphia (CHOP) have developed a preclinical, potent therapy attached to an antibody that targets a surface protein expressed in most childhood neuroblastomas, effectively killing...
836 views, By Addgene
Addgene, the global nonprofit plasmid repository, announces a new collaboration with the Rett Syndrome Research Trust (RSRT) to advance new and ongoing research with MECP2.
70 views, By Biochempeg Scientific Inc.
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins.
55 views, By Biochempeg Scientific Inc.
Polyethylene glycol (PEG) is a biocompatible, synthetic, hydrophilic polyether compound that has many applications, mostly in the medical industry, but also in the chemical and industrial sectors.
87 views, By Biochempeg
Type 2 diabetes is the most common form of diabetes. Semaglutide is an agonist of glucagon-like peptide-1 (GLP-1) receptor that is developed to treat type 2 diabetes. It reduces blood sugar via increasing the production of insulin.

Page: 1 Page updated every 30 minutes

Like PRLog?
Click to Share